Biomedical Engineering

Targeted lipid nanoparticles for immunotherapy applications

University of Strathclyde

Strathclyde Institute of Pharmacy and Biomedical Sciences

Location
Glasgow, United Kingdom
Funding
While there is no funding in place for opportunities marked "unfunded", there are lots of different options to help you fund postgraduate research. Visit funding your postgraduate research for links to government grants, research councils funding and more, that could be available.
Application deadline
See university guidance

Key facts

  • Opens: Monday 16 November 2026
  • Number of places: 2
  • Duration: 48 months

Eligibility

The successful candidate will hold an upper second class UK degree or equivalent in Biology, Biochemistry, Biomedical Engineering, or Chemistry, or any other relevant discipline.

Project Details

This PhD project will develop targeted lipid nanoparticle (LNP) systems capable of delivering messenger RNA (mRNA) encoding therapeutic antibodies directly to tumour-associated cells, enabling in vivo antibody production for cancer immunotherapy. The student will design and optimise antibody-encoding mRNA constructs and formulate LNPs with favourable physicochemical properties for efficient delivery and expression.

During the early stages of the project, a library of LNP formulations will be developed and characterised for particle size, encapsulation efficiency, stability, and transfection performance. Tumour-targeting strategies, including ligand-functionalised nanoparticles directed towards cancer cells, cancer-associated fibroblasts, or tumour-associated macrophages, will then be investigated to enhance the specificity and localisation of antibody expression within the tumour microenvironment.

Subsequent work will evaluate the anti-tumour efficacy of this platform using advanced in vitro and in vivo cancer models. The project will assess antibody production, cellular uptake, biodistribution, immune activation, and tumour growth inhibition, alongside detailed molecular and immunological profiling. In the later stages, the student will explore benchmarking against more advanced therapeutic approaches, including the delivery of checkpoint inhibitors or bispecific immune-engaging antibodies, while assessing manufacturability and translational potential.

By establishing a platform for localised antibody production within tumours, this research aims to overcome key limitations of conventional monoclonal antibody therapy, offering a potentially more effective, cost-efficient, and scalable strategy for the treatment of cancer.

Funding details

While there is no funding in place for opportunities marked "unfunded", there are lots of different options to help you fund postgraduate research. Visit funding your postgraduate research for links to government grants, research councils funding and more, that could be available.

Dr Zahra Rattray

Professor Strathclyde Institute of Pharmacy and Biomedical Sciences

Professor Yvonne Perrie

Head Of Institute Strathclyde Institute of Pharmacy and Biomedical Sciences

Apply

Number of places: 2

To read how we process personal data, applicants can review our 'Privacy Notice for Student Applicants and Potential Applicants' on our Privacy notices' web page .

SIPBS (Biomedical Sciences)

Programme: SIPBS (Biomedical Sciences)

Contact us

zahra.rattray@strath.ac.uk

Research areas

Biomedical EngineeringBiochemistryengineeringEngineeringBiomedicalChemistryBiology

Related PhD opportunities

PhD Biomedical Engineering

Burn and trauma testing for limb experimental models (BATTLE)

University of Southampton

This project will investigate cellular and molecular responses to mechanical and thermal injury, using complementary preclinical models to…

Location
Southampton, United Kingdom
Deadline
Funding
Tax-free stipend; £27,000 per year
PhD Biomedical Engineering

Engineering bioreducible polymer nanoparticles for CRISPR-Cas precision medicine

Queen's University Belfast

Proliferation of CRISPR-Cas methods has sparked a revolution in genome engineering and precision medicine. Specific genes can now be…

Location
Belfast, United Kingdom
Deadline
See university guidance
Funding
Studentship; Maintenance stipend and eligible tuition fees at the applicable DfE rates; Eligible tuition fees
Postdoc Biomedical Engineering

Postdoctoral Research Assistant - UOD2469

University of Dundee

University of Dundee | Faculty of Science, Engineering and Business Part-time (0.5 FTE), fixed-term: 1 December 2026-21 November 2027…

Location
Dundee, United Kingdom
Deadline
Funding
See university guidance